Journal
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Volume 18, Issue 1, Pages S116-S124Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.bbmt.2011.10.019
Keywords
Acute GVHD; Chronic GVHD; Biomarkers; Allogeneic hematopoietic cell transplantation
Categories
Funding
- NIH [CA039542, HL101102]
Ask authors/readers for more resources
Acute and chronic graft-versus-host disease (aGVHD, cGVHD) are serious complications of allogeneic hematopoietic cell transplantation. The complex pathophysiology of these disease processes is associated with immune system activation, the release of cytokines and chemokines, and alterations in cell populations. The blood levels of specific protein and cellular levels in patients with GVHD have correlated with the development, diagnosis, and prognosis of GVHD. Here, we review the most promising biomarkers for aGVHD and cGVHD with clinical relevance. The utility of GVHD biomarkers in clinical care of allogeneic hematopoietic cell transplantation recipients needs to be proven through clinical trials, and potential approaches to trial design are discussed. Biol Blood Marrow Transplant 18: S116-S124 (2012) (C) 2012 American Society for Blood and Marrow Transplantation
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available